(Q36134905)

12 August 2017

Metabolic effects of pamidronate in patients with metastatic bone disease (English)

1 reference

12 August 2017

Vinholes J

1

1 reference

12 August 2017

Guo CY

2

1 reference

12 August 2017

Purohit OP

3

1 reference

12 August 2017

Eastell R

4

1 reference

12 August 2017

Coleman RE

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

73

1 reference

12 August 2017

9

1 reference

12 August 2017

1089-1095

1 reference

High-dose intravenous pamidronate for metastatic bone pain

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Biochemical prediction of response of bone metastases to treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Treatment of bone metastases from breast cancer and myeloma with pamidronate.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Controlled Clinical Study on the Use of Dichloromethylene Diphosphonate in Patients with Breast Carcinoma Metastasizing to the Skeleton

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Biochemical markers of bone turnover in women with surgically treated carcinoma of the breast.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074415

Calcium excretion (CaE) in metastatic breast cancer

23 September 2018

1 reference

12 December 2020

Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease

1 reference

12 December 2020

Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma

1 reference

12 December 2020

The response evaluation of bone metastases in mammary carcinoma. The value of radiology, scintigraphy, and biochemical markers of bone metabolism

1 reference

12 December 2020

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

1 reference

12 December 2020

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

12 December 2020

Palliative pamidronate treatment in patients with bone metastases from breast cancer

1 reference

12 December 2020

Increased urinary excretion of pyridinium cross-links in cancer patients

1 reference

12 December 2020

Effect of clodronate treatment on bone scintigraphy in metastatic breast cancer

1 reference

12 December 2020

Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease

1 reference

12 December 2020

Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis

1 reference

12 December 2020

Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays

1 reference

12 December 2020

Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.210

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

8624269

1 reference